ICU Medical Inc (NASDAQ: ICUI) has reported earnings for its third fiscal quarter (ending September 30) of $0.30 versus a loss $-0.55 for the same period a year ago. This result fell short of the […]
Gol Linhas Aereas Inteligentes S (NYSE: GOL) has reported E.P.S. of $-1.25 for its third fiscal quarter (ending September 30) versus $-1.37 for the same period a year ago. This result fell short of the […]
Idaho Strategic Resources Inc (NYSEAMERICAN: IDR) has reported E.P.S. of $0.03 for its third fiscal quarter (ending September 30) versus $-0.16 for the same period a year ago. For the latest four quarters through September […]
International Flavors & Fragranc (NYSE: IFF) has reported E.P.S. of $0.10 for its third fiscal quarter (ending September 30) versus $-8.60 for the same period a year ago. Relative to the consensus estimate of $0.75, […]
Digimarc Corp (NASDAQ: DMRC) has reported E.P.S. of $-0.53 for its third fiscal quarter (ending September 30) versus $-0.76 for the same period a year ago. This result fell short of the consensus estimate of […]
Teradata Corporation (NYSE: TDC) has reported E.P.S. of $0.12 for its third fiscal quarter (ending September 30) versus $0.08 for the same period a year ago — an increase of 50%. However, this performance was […]
ALLETE Inc. (NYSE: ALE) has reported E.P.S. of $1.50 for its third fiscal quarter (ending September 30) versus $0.59 for the same period a year ago — an increase of 154%. Relative to the consensus […]
For its third fiscal quarter (ending September 30), Eli Lilly and Co (NYSE: LLY) has reported a -104% decline in E.P.S. from $1.61 a year ago to $-0.06 in the current quarter. This performance was […]
Cedar Fair LP (NYSE: FUN) has reported earnings for its third fiscal quarter (ending September 30) of $4.23 versus $5.91 for the same period a year ago — a decline of -28%. However, this result […]
Consolidated Edison Inc. (NYSE: ED) has reported E.P.S. of $1.53 for its third fiscal quarter (ending September 30) versus $1.73 for the same period a year ago — a decline of -12%. Relative to the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research